BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
Despite the advent of new therapies and improved outcomes in patients with pulmonary arterial hypertension (PAH), it remains a life-shortening disease and the time to diagnosis remains unchanged. Strategies to improve outcomes are therefore currently focused on earlier diagnosis and a treatment appr...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2020-05-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/29/156/200009.full |